My Portfolio
+
LINK YOUR PORTFOLIO

Dbv Technologies SA DBV-FR:Euronext Paris

*Data is delayed | Exchange | EUR
Last | 06/03/26 CEST
3.04UNCH (UNCH)
52 week range
1.30 - 4.50
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close3.04
  • 52 Week High4.50
  • 52 Week High Date12/17/25
  • 52 Week Low1.30
  • 52 Week Low Date06/03/25

Latest On Dbv Technologies SA

Key Stats

  • Market Cap898.843M
  • Shares Out296.06M
  • 10 Day Average Volume1.28M
  • Dividend-
  • Dividend Yield-
  • Beta-0.85

Latest On Dbv Technologies SA

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close3.04
  • 52 Week High4.50
  • 52 Week High Date12/17/25
  • 52 Week Low1.30
  • 52 Week Low Date06/03/25
  • Market Cap898.843M
  • Shares Out296.06M
  • 10 Day Average Volume1.28M
  • Dividend-
  • Dividend Yield-
  • Beta-0.85

RATIOS/PROFITABILITY

  • EPS (TTM)-0.91
  • P/E (TTM)-3.34
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-124.22M
  • ROE (TTM)-150.04%
  • Revenue (TTM)4.846M
  • Gross Margin (TTM)-
  • Net Margin (TTM)-2,611.00%
  • Debt To Equity (MRQ)3.87%

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Profile

MORE
DBV Technologies SA is a France-based clinical-stage biopharmaceutical company focused on changing the field of immunotherapy by developing a technology platform called Vaskin. The Company's therapeutic approach is based on epicutaneous immunotherapy, or EPIT, its proprietary method of delivering biologically active compounds to the immune system through intact skin using Viaskin. It dedicates its technology to treat patients, including infants and children, suffering from...
Michel de Rosen
Non-Executive Independent Chairman of the Board
Daniel Tasse
Chief Executive Officer, Director
Virginie Boucinha
Chief Financial Officer
Address
Batiment IRO, 107 Av. de la Republique
Chatillon
92320
France